Habil Khorakiwala, founder and chairman, Wockhardt Synopsis Wockhardt’s Habil Khorakiwala has seen the most harrowing days. From a payment default to bond holders to troubled factories, Khorakiwala pulled the company Continue Reading
India, home to the world’s largest low- and middle-income (LMIC) population, is now facing a weighty challenge — literally. It accounts for a staggering 15% of the global obesity burden, Continue Reading
“It is a small emergency,” says Amit Bakshi, chairman of Ahmedabad-based drugmaker Eris Lifesciences. He points to the recent decision of Novo Nordisk, the world’s top seller of insulin, to Continue Reading
It is important for state-run health insurance to ensure more hospitals join to provide a safety net to the poor.
Genetic structure could hold some answers to the vexed issue of cancer. A reference set of genetic variants, specific to India’s diverse ethnic groups, can improve disease modelling and treatment.
Getty Images Guillain-Barre syndrome (GBS) test, a rare disorder where the body’s immune system damages nerve Synopsis Guillain-Barré Syndrome is a rare nerve disorder. It is not a communicable disease. Continue Reading
Cyril Konto, CEO, Ichnos Glenmark Innovation and Glenn Saldanha, CMD, Glenmark Pharma; image credit: Glenmark. Synopsis The drug has given promising results for the treatment of multiple myeloma, a rare Continue Reading
Umang Vohra, Global CEO, Cipla. Will Cipla’s big bet work?; image credit: Company. Synopsis Millions of diabetes patients have to take a painful insulin injection to keep sugar levels in Continue Reading
Private equity investors have been investing large sums of money in hospitals. Certain types of hospital chains are delivering healthy returns for such investors.
Navjot Singh Sidhu with wife Navjot Kaur Sidhu Synopsis Navjot Singh Sidhu claimed his wife’s advanced-stage cancer was cured through alternative remedies, sparking controversy. His suggestion that fasting could kill Continue Reading
Doctors are grappling with a raft of unsparing hospital-acquired superbugs broadly known as anti-microbial resistance or AMR. Are bacterial infections the next big lethal adversary for mankind?
Collage by Manali Ghosh Synopsis 23andMe, a pioneer in genetic testing, struggles to maintain its early success. As quickly as it soared, its market value plummeted, leaving the company’s future Continue Reading
Apollo Hospital in Mumbai, India. Synopsis Strong financial and operational performance marked the last five years, a consolidation phase for the company. While the robust balance sheet will provide Apollo Continue Reading
Doctors have earned a place of reverence and high esteem in Indian society. They have been known to selflessly care for patients, a trait that was in ample display during Continue Reading
Synopsis If Torrent Pharma were to acquire Cipla, which is 2.5 times its size in sales, it would be a bold move. While the acquisition would catapult Torrent to the Continue Reading
Syngene International Limited via Facebook Synopsis Despite robust growth prospects acting as a booster dose for the valuation of contract research and manufacturing company Syngene, investors are expected to remain Continue Reading
“When I started practice in India about 30 years ago, I would see a person under 30 years or between 30 and 35 years with some heart trouble only once Continue Reading
Health workers wearing personal protective equipment (PPE) take part in a mock drill to check preparations of Covid-19 facilities at JLNM hospital in downtown Srinagar on April 10, 2023. Synopsis Continue Reading
Yan Chow, global healthcare leader, Automation Anywhere Synopsis The healthcare industry is on the verge of a transformation due to the increasing demands and the challenges it faces. Historically, advances Continue Reading
Mark Cuban. Synopsis Most of the large Indian pharma companies earn a big chunk of their revenue by supplying drugs to the US market. Shark Tank attraction Cuban’s online pharmacy Continue Reading
Cyriac Abby Philips, popular on X as Liverdoc, has waged an unyielding battle against alternative medicines like Ayurveda, Homeopathy, Unani and Siddha. This is a daunting task given the deep Continue Reading
Liver specialist Cyriac Abby Philips says there are no approved medicines for treating NASH or non-alcoholic steatohepatitis. Synopsis November 14 was World Diabetes Day. With over 100 million patients, India Continue Reading
Cui Xiaotian, Zhao Jinzhao, Zhou Xinda, Hua Ang, Chengxi, Tan Chen, and Han Wei Liu Ping, a 25-year-old living in Beijing, is queuing up outside the obesity clinic of the Continue Reading
Synopsis Improving financials of hospital chains, future growth prospects of the sector itself have attracted investors to hospital stocks. But while Apollo Hospitals and Max Healthcare led the gains post Continue Reading
Getty Images Synopsis The irreversible lung disease is affecting a large part of India’s population, especially the elderly. It is the biggest cause of mortality after heart ailments, while the Continue Reading
Three months ago, Robert M Califf, commissioner of the US Food and Drug Administration (USFDA) visited India to strengthen efforts on development, supply, and quality of drugs. For the US, Continue Reading
Using indigenous proprietary technology, scientists at the institute are slicing the brain down to one-fifth of a human hair to build a bank of images several times sharper in resolution Continue Reading
For a moment, one might mistake it for a corporate office. Shiny cars pulling over. Executives in dapper suits sauntering in. That’s how the FDA Bhawan — the headquarters of Continue Reading
India’s smaller cities and hinterland remain a neglected lot even as five-star specialty hospitals flourish in the metros. To have its healthcare parameters on track, India needs an urgent flow Continue Reading
Maziar Mike Doustdar, executive VP, Novo Nordisk; image credit: Company Synopsis Novo Nordisk, the most valuable pharmaceutical company in the world, turned 100 last year. While it is largely known Continue Reading
Does serendipity help pharmaceutical companies rake in megabucks? Well, if one were to trace the genesis of some key blockbuster drugs of recent years, it becomes evident that luck has Continue Reading
Synopsis While Ramesh Juneja has led Mankind Pharma for three decades, his brother Rajeev kept in tow and took charge of key operations. Suave and yet rustic, the younger Juneja Continue Reading
The ImmunoACT team that worked on India’s first approved CAR-T therapy NexCAR 19; image courtesy: ImmunoACT Synopsis NexCAR 19, India’s first cell therapy to treat a specific form of blood Continue Reading
Synopsis Orchid Pharma had outlicensed its experimental antibiotic drug to Allecra Therapeutics of Germany. After years of research that drug has won crucial approvals from the US FDA and European Continue Reading
As long-haul infections continue to surge, and climate change pushes ticks into new habitats, finding out the causes of these conditions and coming up with cures will become ever more Continue Reading
Chris Boerner, Global CEO, Bristol Myers Squibb; image credit: BMS Synopsis “We are building to be one of the fastest-growing companies by the end of the decade,” says Chris Boerner, Continue Reading
What’s common among Augmentin, Clavam, and Omnicef? Well, these are among the most widely prescribed antibiotic drugs in India made by leading pharmaceutical companies including GSK, Alkem Laboratories, and Aristo Continue Reading
Ranjit Shahani, former chief of Novartis Synopsis Ranjit Shahani will be remembered for his astute leadership and trademark calmness amid chaos. As chief of Novartis in India for nearly two Continue Reading
No free gifts. No free Thailand (or Maldives) trips. No “free lunches” at expensive restaurants. In short, that is the clear message from the government to the pharmaceutical industry. The Continue Reading
Is the pharma market, which is currently at INR2.17 lakh crore (USD25.8 billion), getting too crowded? While some industry experts believe a few clear signs of fatigue have emerged, many Continue Reading
An overlooked mental health challenge faced by new mothers. A powerful new drug Zurzuvae could be critical in fighting back. It should have been an obvious match. Yet things may Continue Reading
Synopsis With an alarming rise in cancer diagnosis rate in India, especially among the younger cohort, timely screening and therapeutic intervention are the need of the hour. One small state Continue Reading
Illustration by Sadhana Saxena via AI. Synopsis Advent, which merged Suven Pharma with Cohance Lifesciences in February, looks to take advantage of the China+1 wave and other geopolitical tailwinds. While Continue Reading
The government is finally addressing the need for basic rules around pharma recalls.
As per a recent report in The Lancet, the incidence of prostate cancer is expected to double in India over the next few years. A crucial weapon in averting a Continue Reading
When Rajesh Singh was posted as an excise inspector in Agra in 2019, he did not think he will become an important catalyst for a crucial amendment in India’s 80-year-old Continue Reading
Credit: illustration by Sadhana Saxena via Ai Synopsis Something as cool as a J-Labs can be a welcome step. From fear of failing, scientists can look at the opportunities of Continue Reading
Synopsis Most Indians are sleep-deprived and are turning to melatonin for a better night’s rest. The global melatonin market reached USD2.15 billion in 2022, and India’s sleep aid market is Continue Reading
Shares of Sun Pharmaceuticals, India’s largest drug manufacturer, gained more than 50% over the last one year. In its latest results, the company also posted a 34% on year jump Continue Reading
Japanese researchers are soon embarking on human clinical trials for a medicine that will help regrow teeth.
Sudhir Srivastava (centre) with his expanding team at SS Innovations; image credit: SS Innovations Synopsis In an exclusive interaction with ET Prime, cardiac surgeon Sudhir Prem Srivastava, the man behind Continue Reading
Advent controlled-BSV has charted an exceptional turnaround over the last five years, seeing a 3x jump in its valuation. Its specialised products in women’s health and a robust research pipeline Continue Reading
Sarah McMullen, USFDA India director Synopsis In the past, many within the Indian pharma industry looked at US FDA audits as motivated and a larger conspiracy against it. But this Continue Reading
Dilip Shanghvi, managing director, Sun Pharma Synopsis Selling weight-loss drugs is an opportunity no pharma company wants to miss. Now a leading drug maker from India joins this bandwagon. Trust Continue Reading
Ranjan Pai is among India’s most influential investors. So, when he makes a move into senior care, it is time to sit up and take notice of the sector, not Continue Reading
A recent animal study has proven green jackfruit flour’s potency in treating fatty liver and liver cancer. An expert group of doctors, scientists and researchers are coming together to initiate Continue Reading
Synopsis Last year, Sun Pharma infused over INR4,688 crore to buy US-based Concert Pharma. That deal gave it rights to a drug that helps hair growth in patients suffering from Continue Reading
Kolkata woman PGT doctor rape-murder: Junior doctors hold protest in state-run hospitals Synopsis The tragic case in Kolkata’s RG Kar Medical College once again exposed the deep flaws in India’s Continue Reading
Mpox is the latest scare word ripping through the world. The pressing questions are: Is a deadly pandemic like Covid-19 already here? Do we have an effective vaccine ready in Continue Reading
Infertility, once shrouded in cultural taboos and superstition, has emerged as a critical health issue worldwide. In India, the narrative is no different. Let’s reflect on Bimla’s story. She struggled Continue Reading
Chaitanya Sarawate, president and CEO of GE HealthCare South Asia and managing director of Wipro GE Healthcare; image credit: company. Synopsis GE HealthCare is riding high on the India opportunity. Continue Reading
In the crosshairs of the latest controversy on whether a drug is spurious or “not of standard quality” is the Indian patient. The pharma industry suffered a body blow recently Continue Reading
Natco Pharma failed to maintain cleanliness, sterilise equipment and utensils at appropriate intervals at its Telangana-based plant, as per the US health regulator. In the warning letter to the company, Continue Reading
Pharma major Cipla Ltd will acquire the cosmetics and personal care distribution and marketing business of Ivia Beaute Pvt Ltd, including the latter’s brands Astaberry, Ikin and Bhimsaini, on a Continue Reading
Drug major Cipla Wednesday reported over two-fold jump in consolidated net profit to Rs 357.68 crore for the fourth quarter ended March 31, mainly on account of robust sales across Continue Reading
Glenmark Pharmaceuticals Friday said it has received final approval from the US health regulator for Ezetimibe and Simvastatin tablets, used for treating high levels of cholesterol in the blood. Citing Continue Reading
Adhish Patil, CFO, Aarti Drugs Ltd, talks about Q3FY21 numbers, PLI Scheme, CapEx and budget expectations during a candid chat with Swati Khandelwal, Zee Business in the run-up to the Continue Reading
In today’s episode of News Par Views, Zee Business Managing Editor Anil Singhvi spoke to Sandeep Garg, Joint Managing Director (Jt MD) of IOL Chemicals. The company was started in 1986 and is Continue Reading
The company has inked a licensing pact with the NewJersey-based drug firm to acquire rights in Brimonidine Tartrate Ophthalmic Solution 0.025 percent, the Hyderabad-based firm said in a statement. As Continue Reading
For some sectors, it’s good news, and for some it’s bad, the dollar index has jumped to a five-week high on Friday to 109 level, which is the highest since Continue Reading
Sun Pharmaceuticals Industries stocks gained on Tuesday on positive July-September quarter estimates. The scrip quoted Rs 1034 apiece on NSE, up 1 per cent, in afternoon session. The drug maker also Continue Reading
World-leading healthcare specialists Bravo Pharma have officially entered a strategic partnership with the region’s pioneering AI-powered healthcare company G42 Healthcare. In addition to this partnership, Bravo Pharma has also organized Continue Reading
Shares of Cipla surged more than 6 per cent in morning trade on Friday to hit a fresh 52-week high amid the buzz over one of largest global private equity Continue Reading
Torrent Pharmaceuticals Ltd shares registered a new 52-week high of Rs 2,089.85 per piece on the BSE on Tuesday after the company reported a rise in net profit and revenue Continue Reading
